These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1927944)

  • 1. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N; Kashiwagi A; Nishio Y; Kikkawa R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
    Reaven PD; Parthasarathy S; Beltz WF; Witztum JL
    Arterioscler Thromb; 1992 Mar; 12(3):318-24. PubMed ID: 1547191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
    McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL
    Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
    Mao SJ; Yates MT; Parker RA; Chi EM; Jackson RL
    Arterioscler Thromb; 1991; 11(5):1266-75. PubMed ID: 1911712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probucol on hypercholesterolemia in renal transplant patients.
    Okubo M; Nakamura M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Endo T
    Kidney Int Suppl; 1999 Jul; 71():S229-30. PubMed ID: 10412784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
    Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
    Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
    Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
    Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.
    Lins RL; Matthys KE; Billiouw JM; Dratwa M; Dupont P; Lameire NH; Peeters PC; Stolear JC; Tielemans C; Maes B; Verpooten GA; Ducobu J; Carpentier YA
    Clin Nephrol; 2004 Oct; 62(4):287-94. PubMed ID: 15524059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol normalizes cholesteryl ester transfer in IDDM.
    Bagdade JD; Stein E; Ritter MC
    Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive correlation between probucol in low density lipoprotein and LDL-lowering.
    Shinomiya M; Shirai K; Saito Y; Yoshida S
    Eur J Clin Pharmacol; 1993; 45(4):343-6. PubMed ID: 8299667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Regnström J; Nilsson J; Johansson J; Schäfer-Elinder L; Moelgaard J; Hådell K; Olsson AG; Carlson LA
    Am J Cardiol; 1993 Feb; 71(6):15B-19B. PubMed ID: 8434556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.